Fluorine in PDB 7rw5: Crystal Structure of Human Methionine Adenosyltransferase 2A (MAT2A) in Complex with Sam and Allosteric Inhibitor Compound 1

Enzymatic activity of Crystal Structure of Human Methionine Adenosyltransferase 2A (MAT2A) in Complex with Sam and Allosteric Inhibitor Compound 1

All present enzymatic activity of Crystal Structure of Human Methionine Adenosyltransferase 2A (MAT2A) in Complex with Sam and Allosteric Inhibitor Compound 1:
2.5.1.6;

Protein crystallography data

The structure of Crystal Structure of Human Methionine Adenosyltransferase 2A (MAT2A) in Complex with Sam and Allosteric Inhibitor Compound 1, PDB code: 7rw5 was solved by L.Jin, A.K.Padyana, with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:

Resolution Low / High (Å) 37.92 / 2.48
Space group P 1 21 1
Cell size a, b, c (Å), α, β, γ (°) 68.237, 103.99, 113.972, 90, 93.47, 90
R / Rfree (%) 17.5 / 22.9

Fluorine Binding Sites:

The binding sites of Fluorine atom in the Crystal Structure of Human Methionine Adenosyltransferase 2A (MAT2A) in Complex with Sam and Allosteric Inhibitor Compound 1 (pdb code 7rw5). This binding sites where shown within 5.0 Angstroms radius around Fluorine atom.
In total only one binding site of Fluorine was determined in the Crystal Structure of Human Methionine Adenosyltransferase 2A (MAT2A) in Complex with Sam and Allosteric Inhibitor Compound 1, PDB code: 7rw5:

Fluorine binding site 1 out of 1 in 7rw5

Go back to Fluorine Binding Sites List in 7rw5
Fluorine binding site 1 out of 1 in the Crystal Structure of Human Methionine Adenosyltransferase 2A (MAT2A) in Complex with Sam and Allosteric Inhibitor Compound 1


Mono view


Stereo pair view

A full contact list of Fluorine with other atoms in the F binding site number 1 of Crystal Structure of Human Methionine Adenosyltransferase 2A (MAT2A) in Complex with Sam and Allosteric Inhibitor Compound 1 within 5.0Å range:
probe atom residue distance (Å) B Occ
B:F402

b:50.8
occ:1.00
 FAV B:7U2402 0.0 50.8 1.0
CAU B:7U2402 1.4 46.7 1.0
CAT B:7U2402 2.4 49.9 1.0
CAW B:7U2402 2.4 43.2 1.0
CAS B:7U2402 2.9 52.3 1.0
CE2 B:PHE20 3.1 21.8 1.0
CAM B:7U2402 3.2 44.0 1.0
CD2 A:LEU315 3.2 24.3 1.0
CBA B:7U2402 3.3 45.3 1.0
NAR B:7U2402 3.6 50.8 1.0
CAX B:7U2402 3.7 39.5 1.0
CAZ B:7U2402 3.7 44.4 1.0
CAK B:7U2402 3.8 41.8 1.0
CZ B:PHE20 3.9 21.5 1.0
CAL B:7U2402 4.0 45.3 1.0
CD2 B:PHE20 4.1 25.6 1.0
CAY B:7U2402 4.2 37.7 1.0
CE1 A:PHE139 4.2 26.6 1.0
CAQ B:7U2402 4.6 48.2 1.0
CG A:LEU315 4.6 28.6 1.0
CAJ B:7U2402 4.6 44.9 1.0
CBB B:7U2402 4.6 46.3 1.0
CZ A:PHE139 4.7 24.7 1.0
CB A:ALA276 4.9 24.0 1.0
N3 B:7U2402 5.0 48.3 1.0
O B:GLY273 5.0 27.7 1.0

Reference:

M.Li, Z.Konteatis, N.Nagaraja, Y.Chen, S.Zhou, G.Ma, S.Gross, K.Marjon, M.L.Hyer, E.Mandley, M.Lein, A.K.Padyana, L.Jin, S.Tong, R.Peters, J.Murtie, J.Travins, M.Medeiros, P.Liu, V.Frank, E.T.Judd, S.A.Biller, K.M.Marks, Z.Sui, S.K.Reznik. Leveraging Structure-Based Drug Design to Identify Next-Generation MAT2A Inhibitors, Including Brain-Penetrant and Peripherally Efficacious Leads. J.Med.Chem. V. 65 4600 2022.
ISSN: ISSN 0022-2623
PubMed: 35293760
DOI: 10.1021/ACS.JMEDCHEM.1C01595
Page generated: Fri Aug 2 12:36:07 2024

Last articles

Zn in 9JYW
Zn in 9IR4
Zn in 9IR3
Zn in 9GMX
Zn in 9GMW
Zn in 9JEJ
Zn in 9ERF
Zn in 9ERE
Zn in 9EGV
Zn in 9EGW
© Copyright 2008-2020 by atomistry.com
Home   |    Site Map   |    Copyright   |    Contact us   |    Privacy